Fate Therapeutics Inc. sell StockNews.com
Start price
28.06.25
/
50%
€0.88
Target price
28.06.26
-
Performance (%)
-0.82%
Price
02.12.25
€0.86
Summary
This prediction is currently active. Since the start of the prediction for Fate Therapeutics Inc. the price has only changed by -0.82%. This prediction currently runs until 28.06.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fate Therapeutics Inc. | -5.239% | -5.239% |
| iShares Core DAX® | 0.697% | -0.987% |
| iShares Nasdaq 100 | 1.661% | -1.837% |
| iShares Nikkei 225® | 0.922% | -7.458% |
| iShares S&P 500 | 0.430% | -0.851% |
Comments by StockNews_com for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for FATE provided by MarketBeat
Stopped prediction by StockNews_com for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.15
11.05.24
11.05.24
-
11.05.25
11.05.25
-76.44%
12.05.25
12.05.25
